إعلان
إعلان

LPCN

LPCN logo

Lipocine Inc.

8.06
USD
برعاية
+0.53
+7.04%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
exchange

بعد الإغلاق

8.03

-0.03
-0.37%

تقارير أرباح LPCN

النسبة الإيجابية المفاجئة

LPCN تفوق 27 من 40 آخر التقديرات.

68%

التقرير التالي

بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$118.32K
/
-$0.62
التغير الضمني من Q3 25 (Revenue/ EPS)
+2.89%
/
+5.08%
التغير الضمني من Q4 24 (Revenue/ EPS)
-96.61%
/
-133.33%

Lipocine Inc. earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, LPCN reported earnings of -0.59 USD per share (EPS) for Q3 25, missing the estimate of -0.55 USD, resulting in a -7.12% surprise. Revenue reached 115.00 ألف, compared to an expected 242.76 ألف, with a -52.63% difference. The market reacted with a +3.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.62 USD, with revenue projected to reach 118.32 ألف USD, implying an زيادة of 5.08% EPS, and زيادة of 2.89% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Lipocine Inc. reported EPS of -$0.59, missing estimates by -7.12%, and revenue of $115.00K, -52.63% below expectations.
The stock price moved up 3.13%, changed from $2.56 before the earnings release to $2.64 the day after.
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
Based on 4 المحللين, Lipocine Inc. is expected to report EPS of -$0.62 and revenue of $118.32K for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان